Medication - Medika Life

CATEGORIES

Medication

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

Pat Farrell PhD - June 1, 2025

2024 Health Trends: Progress, Challenges, and Opportunities

Gil Bashe, Medika Life Editor - December 27, 2024

The New Covid Vaccine Is Out. Why You Might Not Want To Rush To Get It

Medika Life - September 22, 2024

10-Year-Old Killers Are Responsible for Their Actions?

Pat Farrell PhD - September 5, 2024

LATEST

Editors Choice

Defeating My Wisdom Teeth

Jordan Forbes - February 21, 2023

Editors Choice

As Opioids Mixed With Animal Tranquilizers Arrive in Kensington, So Do Alarming Health Challenges

Medika Life - February 15, 2023

Editors Choice

“Going One On One With My Wisdom Teeth”

Jordan Forbes - January 18, 2023

Editors Choice

COVID Vaccine Versus Infection: Which Confers More Immunity?

Michael Hunter, MD - January 15, 2023

Editors Choice

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life - January 9, 2023

Editors Choice

Do Probiotics Repair Antibiotic-Induced Gut Damage?

Michael Hunter, MD - November 27, 2022

Editors Choice

This Vaccine Has Been Wildly Successful

Michael Hunter, MD - August 23, 2022

Editors Choice

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Isabella Soerjanto MD - August 2, 2022

Editors Choice

The Subtle Signs of Brewing Violence May Be Seen, But Not Always

Pat Farrell PhD - June 27, 2022

Press Release

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life - April 27, 2022

123 4 Page 2 of 4

TRENDING

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life - January 9, 2023

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

The Power of Lifestyle Choices – The Dose of Truth in “Heal Thyself”

John Whyte MD - April 24, 2022

Exponential Innovation: Disrupting The Disruptor

John Nosta - January 5, 2022

Do Medications Have Psychiatric Side Effects?

Pat Farrell PhD - October 6, 2020

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne - December 14, 2020

Does Botox Drop Anxiety?

Michael Hunter, MD - December 23, 2021

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne - December 14, 2020

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Isabella Soerjanto MD - August 2, 2022

EDITORS CHOICE

Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction

Medika Life - June 29, 2023

DANDRIDGE, Tenn. — Rachel Solomon and judges hadn’t been on the best of terms. Then Judge O. Duane Slone “dumbfounded” her. Solomon was given...

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life - April 27, 2022

Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life - January 9, 2023

Today the Pharmacy Podcast Network announces the winners of the 50 Most Influential Leaders in Pharmacy 2023 Awards.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories